MoneyWorks4Me

The revenue zoomed 12.88% to Rs. 13794.80 millions for the quarter ended September 2022 as compared to Rs. 12220.60 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended September 2022 rise to 38.05% to Rs. 2655.20  millions  compared to R. 1923.30 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 3768.30 millions from 2779.00 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 13794.80 12220.60 12.88 26838.50 24398.90 10.00 49192.70 43100.20 14.14
Other Income 335.30 182.10 84.13 598.90 374.20 60.05 772.10 809.00 -4.56
PBIDT 3768.30 2779.00 35.60 6735.90 5622.60 19.80 11649.30 10023.60 16.22
Interest 39.70 45.10 -11.97 81.90 95.50 -14.24 191.00 182.80 4.49
PBDT 3728.60 2733.90 36.38 6654.00 5527.10 20.39 11458.30 9840.80 16.44
Depreciation 174.70 162.00 7.84 348.20 319.30 9.05 661.00 581.30 13.71
PBT 3553.90 2571.90 38.18 6305.80 5207.80 21.08 10797.30 9259.50 16.61
TAX 898.70 648.60 38.56 1594.20 1326.90 20.14 2810.30 2352.60 19.46
Deferred Tax -18.30 -41.60 -56.01 -30.50 -69.40 -56.05 41.80 -37.90 -210.29
PAT 2655.20 1923.30 38.05 4711.60 3880.90 21.40 7987.00 6906.90 15.64
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 27.32 22.74 20.13 25.10 23.04 8.91 23.68 23.26 1.82
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..